Cite
HARVARD Citation
Müller, T. et al. (2022). Gut–hormone triple agonists: clinical safety and metabolic benefits. Lancet. 400 (10366), pp. 1826-1828. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Müller, T. et al. (2022). Gut–hormone triple agonists: clinical safety and metabolic benefits. Lancet. 400 (10366), pp. 1826-1828. [Online].